BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 10, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 10, 2008
View Archived Issues
Ad5-CMV-NIS gene therapy enters dose-finding phase I study for prostate cancer
Read More
Bayer's PDE9 inhibitor improves memory deficits in animal models
Read More
Metallocomplex targeting iron metabolism novel approach against Pseudomonas infection
Read More
Retargeted adenovirus vector active in preclinical cancer models
Read More
New oncolytic agents disclosed in recent patent literature
Read More
Phase II data from H5 influenza vaccine trial confirms safety and immunogenicity
Read More
ISTA reports phase III results for topical Xibrom in patients undergoing cataract surgery
Read More
AVI files INDs for Ebola virus and Marburg virus treatment trials
Read More
Maas Biolab's intrathecal ciclosporin advances to phase II for ALS treatment
Read More
AC Immune selected as Technology Pioneer 2009 and advances AD program
Read More
Prezista receives expanded E.U. MA for treatment-experienced HIV patients
Read More
Erbitux sBLA for advanced non-small cell lung cancer submitted to FDA
Read More
Novel antithrombotic agents described in recent Boehringer Ingelheim patent
Read More
Recent GSK and Biolipox patents claim novel agents for respiratory disorders
Read More
FDA Advisory Committee recommends approval of Bausch & Lomb's besifloxacin
Read More
Amylin and Lilly provide update on FDA Byetta monotherapy submission
Read More
AstraZeneca and Targacept present top-line results from phase IIb AZD-3480 trial
Read More
Novel drug-loaded microparticles tested in experimental cardiac dysfunction
Read More
FDA grants approval to DOR BioPharma to initiate phase I/II clinical trial of DOR-201
Read More
CyDex receives FDA orphan drug designation for melphalan
Read More
Phase I data and preclinical activity of KW-2449 against leukemia described
Read More
FDA Advisory Committee recommends approval of Genzyme's Synvisc-One
Read More
Kuvan receives marketing approval in the E.U. for hyperphenylalaninemia
Read More
Ablynx initiates phase I study with novel antithrombotic Nanobody
Read More
NF-kappaB inhibitor V-1810 induces multiple myeloma cell death
Read More
